pancreatic cancer

Kumquats
Biotech

Bayer picks Kumquat for $1.3B KRAS collaboration

Bayer has tapped Kumquat for a juicy opportunity, committing up to $1.3 billion to bag a KRAS G12D inhibitor that is on the cusp of the clinic.
Nick Paul Taylor Aug 12, 2025 6:29am
overcome ladder win beat advance obstacle maze

Immuneering sees 94% survival at 6 months in pancreatic cancer

Jun 17, 2025 10:55am
medical data concept with hospital in the background

OSE shares 65% OS rate behind cancer vaccine's phase 2 win

Jun 3, 2025 7:05am
cancer target detection radiopharma radio

Actuate's pancreatic cancer drug boosts survival by 3 months

Jun 2, 2025 7:30am
Novocure TTFields

Novocure's TTFields clear phase 3 pancreatic cancer trial

Dec 2, 2024 11:30am
alligator in pond water

Alligator lets loose 70% of staff, sinking stock 53%

Dec 2, 2024 10:40am